MedTrace Logo

CTT on Renogram as an Early Marker of Significant Obstruction in Uretero-pelvic Junction Syndrome

NCT02812212 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2022-09-29

No results posted yet for this study

Summary

Cortical transit time on diuretic renogram as an early marker of significant obstruction in antenatally detected uretero-pelvic junction syndrome

Conditions

  • Ureteropelvic Junction Obstruction

Interventions

DEVICE

ultrasonography

bilateral ultrasonography to measure the antero-posterior renal pelvic diameter (APRPD) in both positions.

DEVICE

diuretic renography

diuretic renography to measure the cortical transit time.

Sponsors & Collaborators

  • Centre Hospitalier Universitaire de la Réunion

    lead OTHER

Principal Investigators

  • Luke Harper, MD · University Hospital, Bordeaux

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
4 Weeks
Max Age
8 Weeks
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-28
Primary Completion
2026-11-30
Completion
2027-04-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02812212 on ClinicalTrials.gov